Though less frequently found in cancers compared to U2AF1 mutations, U2AF2 mutations were recently identified to cause neurodevelopmental disorders (NDD) in patients presenting with overlapping cognition impairments, hypotonia, seizures, autistic features, and various behavioral disturbances [54–57]. Here, U2AF2 is linked to cancer.